Gene transfer of soluble TGF-β type II receptor inhibits experimental proliferative vitreoretinopathy
- 1 September 2002
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 9 (18) , 1214-1220
- https://doi.org/10.1038/sj.gt.3301789
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 21 references indexed in Scilit:
- Blockade of TGF-β by in vivo gene transfer of a soluble TGF-β type II receptor in the muscle inhibits corneal opacification, edema and angiogenesisGene Therapy, 2000
- Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degenerationGene Therapy, 2000
- A Soluble Transforming Growth Factor beta Receptor Expressed in Muscle Prevents Liver Fibrogenesis and Dysfunction in RatsHuman Gene Therapy, 2000
- The antidepressant hypericin inhibits progression of experimental proliferative vitreoretinopathyCurrent Eye Research, 1999
- A vitrectomy improves the transfection efficiency of adenoviral vector-mediated gene transfer to Müller cellsGene Therapy, 1998
- Retinal Functional Change Caused by Adenoviral Vector-Mediated Transfection of LacZ GeneHuman Gene Therapy, 1998
- Quantitative Analysis of Repeat Adenovirus-Mediated Gene Transfer Into Injured Canine Femoral ArteriesArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Characterization of a Fusion Protein Composed of the Extracellular Domain of c-kit and the Fc Region of Human IgG Expressed in a Baculovirus SystemBiochemical and Biophysical Research Communications, 1993
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992
- Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye.Journal of Clinical Investigation, 1989